- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Hormone-Sensitive Prostate Cancer in United States
Total 8954 results
-
Surface OncologyArcus Biosciences, Inc.CompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
Corcept TherapeuticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States, United Kingdom
-
University of California, DavisSanofiTerminatedHormone-Resistant Prostate Cancer | Stage IV Prostate AdenocarcinomaUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedEnzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate CancerRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Hormone-Resistant Prostate CancerUnited States
-
Mamta ParikhNational Cancer Institute (NCI); PandomedxCompletedMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States
-
University of WashingtonNovartis; Institute for Prostate Cancer Research (IPCR)Not yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
The Christie NHS Foundation TrustAstraZenecaCompletedMetastatic Castration Resistant Prostate CancerUnited Kingdom
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
Emory UniversityNational Cancer Institute (NCI); Prostate Cancer FoundationRecruitingStage IV Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Carolina Research Professionals, LLCBayerUnknownProstate Cancer MetastaticUnited States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
Phoenix Molecular ImagingCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
Fred Hutchinson Cancer CenterPromiCell Therapeutics, Inc.Not yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
University of MichiganCompletedProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
University of WashingtonNational Cancer Institute (NCI)TerminatedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IV Prostate Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Veeda OncologyBayerTerminatedHormone Refractory Prostate CancerUnited States
-
University of FloridaCureVacTerminated
-
CytRxCompletedHormone Refractory Prostate CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterJohns Hopkins University; Memorial Sloan Kettering Cancer Center; United States... and other collaboratorsCompletedMetastatic Castrate-Resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.PfizerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
Progenics Pharmaceuticals, Inc.CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (CONDOR)Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterTerminatedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Eli Lilly and CompanySarah Cannon Development InnovationsCompletedProstate Cancer MetastaticUnited States
-
US Oncology ResearchPfizerCompleted
-
University of ChicagoNorthShore University HealthSystemCompletedRecurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)UnknownCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
Case Comprehensive Cancer CenterRecruitingMetastatic Prostate CancerUnited States
-
Martha MimsRecruitingProstate Cancer | Prostate Cancer MetastaticUnited States
-
University of Alabama at BirminghamCompletedMetastatic Prostate CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedMetastatic Prostate CancerUnited States
-
Queen's Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHormone Refractory Prostate CancerUnited States
-
University of Colorado, DenverCompletedBone Metastases | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Soft Tissue MetastasesUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Prostate Carcinoma Metastatic to the BoneUnited States
-
SanofiTerminated
-
Mayo ClinicNot yet recruitingLocalized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
Power Life Sciences Inc.Not yet recruitingMetastatic Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...FutureChemTerminatedMetastatic Prostate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
University of California, San FranciscoProstate Cancer FoundationRecruitingProstate Cancer | Prostate Cancer MetastaticUnited States